Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy?

Diabetes Care - United States
doi 10.2337/dc11-2282
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Risk Factors for Retinal Microvascular Impairment in Type 2 Diabetic Patients Without Diabetic Retinopathy

PLoS ONE
Multidisciplinary
2018English

Retinal Neurodegeneration in Patients With Type 2 Diabetes Mellitus Without Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Retinal Measurements in Type 2 Diabetic Patients Without Diabetic Retinopathy Using Spectralis Optical Coherence Tomography

Acta Ophthalmologica
MedicineOphthalmology
2018English

Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2011English

A Risk Stratification Tool for Screening for Diabetic Retinopathy Among Type 2 Diabetic Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Serum Homocysteine Level Among Type-2 Diabetic Patients With and Without Diabetic Retinopathy

Acta Scientific Medical Sciences
2019English

Life Without COX 2 Inhibitors: Opioids Can Be Prescribed Safely in Osteoarthritis

BMJ
2006English

Retinal Imaging Techniques for Diabetic Retinopathy Screening

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2016English

Retinal Vascular Tortuosity in Hospitalized Patients With Type 2 Diabetes and Diabetic Retinopathy in China

Journal of Biomedical Science and Engineering
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy